Effect of endogenous estradiol levels on bone resorption and bone mineral density in healthy postmenopausal women: a prospective study

References

• Consensus Development Conference, Hong Kong, 1993. Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 1994; 90: 646–650
   Google Scholar
• Albright F, Smith P H, Richardson A M. Postmenopausal osteoporosis: its clinical features. JAMA 1941; 1116: 2465–2474
   Google Scholar
• Kalu D N. The ovariectomized rat model of postmenopausal loss bone. Bone Miner 1991; 15: 175–191
   PubMedGoogle Scholar
• Kalu D N, Liu C C, Salerno E, Hollis B, Echon R, Ray M. Skeletal response of ovariectomized rats to low and high dose of 17β-estradiol. Bone Miner 1991; 14: 175–187
   PubMedGoogle Scholar
• Lindsay R, Aitken J M, Anderson J B, et al. Long-term prevention of postmenopausal osteoporosis by estrogen: evidence for an increased bone mass after delayed onset of estrogen treatment. Lancet 1976; 1: 1038–1041
   PubMed Web of Science ®Google Scholar
• Well G, Tugwell P, Shea B, et al. Meta-analyses of therapies for postmenopausal osteoporosis. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocr Rev 2002; 23: 529–539
   PubMed Web of Science ®Google Scholar
• Riggs B L, Khosla S, Melton L J, III. Sex steroids and the construction and observations of the adult skeleton. Endocr Rev 2002; 23: 279–302
   PubMed Web of Science ®Google Scholar
• Riggs B L, Khosla S, Melton L J. A unitary model for involutional osteoporosis: estrogen deficiency causes both Type I and Type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 1998; 13: 763–773
   PubMed Web of Science ®Google Scholar
• Eastell R. Osteoporosis. Oxford Text Book of Endocrinology and Diabetes, J AH Wass, S M Shalet. Oxford University Press, Oxford 2002; 665–675
   Google Scholar
• Gallagher J C, Riggs B L, Eisman J, Hamstra A, Arnaud S B, DeLucas H F. Intestinal calcium absorption and serum vitamin D metabolisms in normal subjects and osteoporotic patients: effect of age and dietary calcium. J Clin Invest 1979; 64: 729–736
   PubMed Web of Science ®Google Scholar
• Slovik D M, Adams J S, Neer R M, Holick M F, Potts J T. Deficient production of 1,25 dihydroxyvitamin D in elderly osteoporotic patients. N Engl J Med 1981; 305: 372–374
   PubMed Web of Science ®Google Scholar
• Riggs B L, Hamstra A, DeLuca H F. Assessment of 25-hydroxyvitamin D-1α reserve in postmenopausal osteoporosis by administration of parathyroid extract. J Clin Endocrinol Metab 1981; 53: 833–835
   PubMed Web of Science ®Google Scholar
• Heaney R P. Calcium dairy products and osteoporosis. J Am Coll Nutr 2000; 19: 83–99S
   PubMed Web of Science ®Google Scholar
• Lips P, Coupron P, Meunier P J. Mean wall thickness of trabecular bone packets in the human iliac crest: changes with age. Calcif Tissue Res 1978; 26: 13–17
   PubMedGoogle Scholar
• Marcus R. New perspectives on the skeletal role of estrogen. J Clin Endocrinol Metab 1998; 83: 2236–2238
   PubMed Web of Science ®Google Scholar
• Reginster J Y, Sarlet N, Deroisy R, Albert A, Gaspard U, Franchimont P. Minimal levels of serum estradiol prevent postmenopausal bone loss. Calcif Tissue Int 1992; 51: 340–343
   PubMed Web of Science ®Google Scholar
• Stone K, Bauer D C, Black D M, Sklarin P, Ensrud K E, Cummings S R. Hormonal predictors of bone loss in elderly women: a prospective study. J Bone Miner Res 1998; 13: 1167–1174
   PubMed Web of Science ®Google Scholar
• Cummings S R, Browner W S, Bauer D, et al. Endogenous hormones and the risk of hip and vertebral fractures among older women. N Engl J Med 1998; 389: 733–738
   Google Scholar
• Ettinger B, Pressman A, Sklarin P, Bauer D C, Cauley J A, Cummings S R. Associations between low levels of serum estradiol bone density and fractures among elderly women: the study of osteoporotic fractures. J Clin Endocrinol Metab 1998; 83: 2239–2243
   PubMed Web of Science ®Google Scholar
• Bagur A, Oliveri B, Mautalen C, et al. Low levels of endogenous estradiol protect bone mineral density in young postmenopausal women. Climacteric 2004; 7: 181–188
   PubMed Web of Science ®Google Scholar
• Zhang H C, Kushida K, Atsumi K, Kink K, Nagano K. Effects of age and menopause on spinal bone mineral density in Japanese women: a ten-year prospective study. Calcif Tissue Int 2002; 70: 153–157
   PubMed Web of Science ®Google Scholar
• Luckey M M, Wallestein S, Lapinski R. A prospective study of bone loss in African. American and white women, a clinical research center study. J Clin Endocrinol Metab 1996; 81: 2948–2956
   PubMed Web of Science ®Google Scholar
• Greendale G A, Edelstein S, Barrett-Connor E. Endogenous sex steroids and bone mineral density in older women and men: The Rancho Bernardo Study. J Bone Miner Res 1997; 12: 1833–1843
   PubMed Web of Science ®Google Scholar
• Vega E, Bagur A, Mautalen C A. Densidad mineral ósea en mujeres osteoporóticas y normales de Buenos Aires. Medicina (Buenos Aires) 1993; 53: 211–216
   PubMedGoogle Scholar
• Lichtenberg V, Schulte-Baukloh A, Lindner Ch. Discrepancies between results of serum 17β-oestradiol (E2) determinations carried out using different immunoassay kits in women receiving oestrogen replacement therapy. Lab Med 1992; 16: 412–415
   Google Scholar
• Thienpont L, Verhseghe P G, Van Brussel K A, De Leenheer A P. Estradiol 17β quantified in serum by isotope dilution gas chromatography-mass spectrophotometry: reversed-phase C18 high-performance liquid chromatography compared with immuno-affinity chromatography for sample pretreatment. Clin Chem 1988; 10: 2066–2069
   Google Scholar
• Farley J R, Hall S L, Llacas D. Quantification of skeletal alkaline phosphatase in osteoporotic serum and wheat germ agglutin precipitation, heat inactivation, and a two-site immunoradiometric assay. Clin Chem 1994; 40: 1749–1756
   PubMed Web of Science ®Google Scholar
• Bonde M, Qvist P, Fledelius C, Riss B J, Christiansen C. Application of an enzyme immunoassay for a new marker of bone resorption (Crosslaps). Follow up on hormone replacement therapy and osteoporosis risk assessment. J Clin Endocrinol Metab 1995; 80: 864–868
   PubMed Web of Science ®Google Scholar
• Trudeau D L, Freir E F. Determination of calcium in urine and serum by atomic absorption spectrophotometry (AAS). Clin Chem 1967; 13: 101–114
   PubMed Web of Science ®Google Scholar
• Muñoz M A, Balon M, Fernandez C. Direct determination of inorganic phosphorus in serum with a single reagent. Clin Chem 1983; 29: 372–374
   PubMed Web of Science ®Google Scholar
• Taussky H H. A microcolorimetric determination of creatinine in urine by the Jaffe reaction. J Biol Chem 1954; 208: 853–860
   PubMed Web of Science ®Google Scholar
• Mazzuoli G, Marinucci D, D'Erasmo E, et al. Cyclical behavior of bone remodeling and bone loss in healthy women after menopause: results of prospective study. Bone 2002; 6: 718–724
   Google Scholar
• Ettinger B, Kristine E, Ensrud E, et al. Effect of ultralow-dose transdermal estradiol on bone mineral density: A randomized clinical trial. Obstet Gynecol 2004; 104: 443–451
   PubMed Web of Science ®Google Scholar
• Huang A J, Ettinger B, Vittinghoff E, Ensrud K E, Johnson K C, Cummings S R. Endogenous estrogen levels and the effects of ultra-low-dose transdermal estradiol therapy on bone turnover and BMD in postmenopausal women. J Bone Miner Res 2007; 22: 1791–1797
   PubMed Web of Science ®Google Scholar
• Jones G, Nguyen T, Sambrook P, Kelly P J, Eisman J A. Progressive loss of bone in the femoral neck in elderly people: longitudinal osteoporosis epidemiology study. Br Med J 1994; 309: 691–695
   PubMed Web of Science ®Google Scholar
• Muñoz Torres M, Jodar E, Quesada M, Escobar-Jimenez F. Bone mass in androgen-insensitivity syndrome: response to hormonal replacement therapy. Calcif Tissue Int 1995; 57: 94–96
   PubMed Web of Science ®Google Scholar
• Kasperk C H, Wakley G, Hierle T, Ziegler R. Gonadal and adrenal androgens are potent regulators of human bone cell metabolism in vitro. J Bone Miner Res 1997; 12: 464–471
   PubMed Web of Science ®Google Scholar
• Wu F, Ames R, Clearwater J, Evans M C, Gamble G, Reid I R. Prospective 10-year study of the determinants of bone density and bone loss in normal postmenopausal women, including the effect of hormone replacement therapy. Clin Endocrinol (Oxf) 2002; 56: 703–711
   PubMed Web of Science ®Google Scholar
• Garcia-Perez M A, Moreno-Mercer J, Tarin J J, Cano A. Relationship between PTH, sex steroid and bone turnover marker measurements and bone density in recently postmenopausal women. Maturitas 2003; 45: 67–74
   PubMed Web of Science ®Google Scholar